Synta Pharmaceuticals Announces Proposed Public Offering of Common Stock

13-11-2013 Business Wire HealthComments (0)

PharmaceuticalSynta Pharmaceuticals

Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that it has commenced an underwritten public offering of shares of its common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Jefferies LLC is acting as the sole book-running manager for the proposed offering. The securities described above are being offer

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top